Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination A US Cohort

被引:169
|
作者
Edelman, Alison [1 ]
Boniface, Emily R.
Benhar, Eleonora
Han, Leo
Matteson, Kristen A.
Favaro, Carlotta
Pearson, Jack T.
Darney, Blair G.
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA
来源
OBSTETRICS AND GYNECOLOGY | 2022年 / 139卷 / 04期
关键词
STRESS;
D O I
10.1097/AOG.0000000000004695
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To assess whether coronavirus disease 2019 (COVID-19) vaccination is associated with changes in cycle or menses length in those receiving vaccination as compared with an unvaccinated cohort. METHODS: We analyzed prospectively tracked menstrual cycle data using the application "Natural Cycles." We included U.S. residents aged 18-45 years with normal cycle lengths (24-38 days) for three consecutive cycles before the first vaccine dose followed by vaccine-dose cycles (cycles 4-6) or, if unvaccinated, six cycles over a similar time period. We calculated the mean within-individual change in cycle and menses length (three prevaccine cycles vs first- and second-dose cycles in the vaccinated cohort, and the first three cycles vs cycles four and five in the unvaccinated cohort). We used mixed-effects models to estimate the adjusted difference in change in cycle and menses length between the vaccinated and unvaccinated cohorts. RESULTS: We included 3,959 individuals (vaccinated 2,403; unvaccinated 1,556). Most of the vaccinated cohort received the Pfizer-BioNTech vaccine (55%) (Moderna 35%, Johnson & Johnson/Janssen 7%). Overall, COVID-19 vaccine was associated with a less than 1-day change in cycle length for both vaccine-dose cycles compared with prevaccine cycles (first dose 0.71 day-increase, 98.75% CI 0.47-0.94; second dose 0.91, 98.75% CI 0.63-1.19); unvaccinated individuals saw no significant change compared with three baseline cycles (cycle four 0.07, 98.75% CI -0.22 to 0.35; cycle five 0.12, 98.75% CI -0.15 to 0.39). In adjusted models, the difference in change in cycle length between the vaccinated and unvaccinated cohorts was less than 1 day for both doses (difference in change: first dose 0.64 days, 98.75% CI 0.27-1.01; second dose 0.79 days, 98.75% CI 0.40-1.18). Change in menses length was not associated with vaccination. CONCLUSION: Coronavirus disease 2019 (COVID-19) vaccination is associated with a small change in cycle length but not menses length.
引用
收藏
页码:481 / 489
页数:9
相关论文
共 50 条
  • [21] The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study
    Jayanama, Kulapong
    Srichatrapimuk, Sirawat
    Thammavaranucupt, Kanin
    Kirdlarp, Suppachok
    Suppadungsuk, Supawadee
    Wongsinin, Thananya
    Nanthatanti, Nithita
    Phusanti, Sithakom
    Pitidhammabhorn, Dhanesh
    Sungkanuparph, Somnuek
    PLOS ONE, 2021, 16 (02):
  • [22] Coronavirus Disease 2019 (COVID-19)-Related Stress and Menstrual Changes
    Anto-Ocrah, Martina
    Valachovic, Tori
    Chen, Michael
    Tiffany, Kimberly
    DeSplinter, Lindsey
    Kaukeinen, Kimberly
    Glantz, J. Christopher
    Hollenbach, Stefanie
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (01): : 176 - 187
  • [23] Effect of COVID-19 vaccination on the menstrual cycle
    Chao, Melissa Jung
    Menon, Carlo
    Elgendi, Mohamed
    FRONTIERS IN MEDICINE, 2022, 9
  • [24] Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study
    Butt, Jawad Haider
    Gerds, Thomas Alexander
    Schou, Morten
    Kragholm, Kristian
    Phelps, Matthew
    Havers-Borgersen, Eva
    Yafasova, Adelina
    Gislason, Gunnar Hilmar
    Torp-Pedersen, Christian
    Kober, Lars
    Fosbol, Emil Loldrup
    BMJ OPEN, 2020, 10 (12):
  • [25] Coronavirus disease 2019 (COVID-19) pandemic in Africa: Current status of COVID-19 vaccination
    Ogunleye, Olayinka O.
    Meyer, C.
    Fadare, Joseph
    Adeoti, Adekunle
    Yinka-Ogunleye, Adesola
    Oyawole, Modupe
    Amu, Adefolarin A.
    Msibi, Mlungisi
    Rashed, Wafaa
    Galal, Ahmad Mahmoud
    Masuka, Nyasha
    Zaranyika, Trust
    Opanga, Sylvia
    Oluka, Margaret
    Mwita, Julius C.
    Rwegerera, Godfrey
    Kgatlwane, Joyce
    Ankrah, Daniel
    Sefah, Israel A.
    Afriyie, Daniel
    Chikowe, Ibrahim
    Khuluza, Felix
    Taruvinga, Tinotenda
    Alfadl, Abubakr
    Malik, Elfatih
    Kalungia, Aubrey C.
    Mudenda, Steward
    Niba, Loveline L.
    Ambindei, Mbam L.
    Godman, Brian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 665 - 666
  • [26] Coronavirus disease 2019 (COVID-19) and priapism: An unexplored association
    Malinga, Dominic Mpumelelo
    Laher, Abdullah E.
    McDowall, Jared
    Adam, Ahmed
    CURRENT UROLOGY, 2022, 16 (02) : 55 - 62
  • [27] Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination
    Takeda, Masahiko
    Ishio, Naoki
    Shoji, Toshihiro
    Mori, Naoto
    Matsumoto, Moe
    Shikama, Nobuaki
    CIRCULATION JOURNAL, 2022, 86 (06) : 1020 - 1020
  • [28] Olfactory dysfunction after coronavirus disease 2019 (COVID-19) vaccination
    Konstantinidis, Iordanis
    Tsakiropoulou, Evangelia
    Hahner, Antje
    de With, Katja
    Poulas, Konstantinos
    Hummel, Thomas
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (09) : 1399 - 1401
  • [29] Postmenopausal Bleeding After Coronavirus Disease 2019 (COVID-19) Vaccination
    Strid, Penelope
    Abara, Winston E.
    Clark, Elizabeth
    Moro, Pedro L.
    Olson, Christine K.
    Gee, Julianne
    OBSTETRICS AND GYNECOLOGY, 2024, 144 (02): : 283 - 287
  • [30] Coronavirus Disease 2019 (COVID-19) Vaccination and Assisted Reproduction Outcomes
    Chamani, Isaac J.
    Taylor, Lauren L.
    Dadoun, Simon E.
    Mckenzie, Laurie J.
    Detti, Laura
    Ouellette, Lara
    Mcculloh, David H.
    Licciardi, Frederick L.
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (02): : 210 - 218